166 related articles for article (PubMed ID: 35249303)
1. [Progress in clinicopathological studies of pulmonary neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count].
Zhang Y; Jiang LL
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):281-286. PubMed ID: 35249303
[TBL] [Abstract][Full Text] [Related]
2. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
[TBL] [Abstract][Full Text] [Related]
3. Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.
Zhang Y; Wang W; Hu Q; Liang Z; Zhou P; Tang Y; Jiang L
BMC Cancer; 2022 Mar; 22(1):321. PubMed ID: 35331190
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary carcinoid and related tumours.
Hasleton PS; Bostanci G
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
[TBL] [Abstract][Full Text] [Related]
5. Classification and Pathology of Lung Cancer.
Zheng M
Surg Oncol Clin N Am; 2016 Jul; 25(3):447-68. PubMed ID: 27261908
[TBL] [Abstract][Full Text] [Related]
6. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
7. Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organization Updates.
Sung S; Heymann JJ; Politis MG; Baine MK; Rekhtman N; Saqi A
Adv Anat Pathol; 2022 Nov; 29(6):329-336. PubMed ID: 36053019
[TBL] [Abstract][Full Text] [Related]
8. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
[TBL] [Abstract][Full Text] [Related]
9. Well-differentiated Neuroendocrine Carcinoma of the Larynx: Confusion of Terminology and Uncertainty of Early Studies.
Hunt JL; Barnes L; Triantafyllou A; Gnepp DR; Devaney KO; Stenman G; Halmos GB; Bishop JA; Skálová A; Willems SM; Hellquist H; Rinaldo A; Ferlito A
Adv Anat Pathol; 2019 Jul; 26(4):246-250. PubMed ID: 31033507
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary Neuroendocrine Tumors.
Borczuk AC
Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
[TBL] [Abstract][Full Text] [Related]
12. High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology: A Study of 12 Cases.
Quinn AM; Chaturvedi A; Nonaka D
Am J Surg Pathol; 2017 Feb; 41(2):263-270. PubMed ID: 27879513
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers help characterize neuroendocrine lung tumors.
Rusch VW; Klimstra DS; Venkatraman ES
Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
15. Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.
Kesrouani C; Ghorra C; Rassy M; Kourie HR; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2579-81. PubMed ID: 27268633
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary neuroendocrine cells in physiology and pathology.
Rydzewska-Rosołowska AE; Kasacka I; Sulewska A; Rudy A; Chyczewski L
Folia Histochem Cytobiol; 2001; 39 Suppl 2():58-63. PubMed ID: 11820629
[TBL] [Abstract][Full Text] [Related]
17. Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx.
Hunt JL; Ferlito A; Hellquist H; Rinaldo A; Skálová A; Slootweg PJ; Willems SM; Cardesa A
Adv Anat Pathol; 2017 May; 24(3):161-168. PubMed ID: 28338500
[TBL] [Abstract][Full Text] [Related]
18. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
[TBL] [Abstract][Full Text] [Related]
19. [Update of pathological diagnosis of pulmonary neuroendocrine tumor].
Teng X; Zhao M; Lai M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):36-44. PubMed ID: 27045239
[TBL] [Abstract][Full Text] [Related]
20. The molecular pathogenesis and management of bronchial carcinoids.
Cakir M; Grossman A
Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
